Annual Revenue: $5,696,380
Net Cash Flow: $3,000,942
Industry: Health Care, Pharmaceutical
Company provides an FDA approved drug product which is proven to safely and effectively prevent a specific type of cancer. Tremendous opportunities exist with very large up-side potential. Extremely low overhead, asset light and can be run from any location. Uniquely insulated from any competitive threat or chance of obsolescence.
Growth and Expansion:
Company currently has two owners who dedicate a few hours per day to its operation. Following a sale, one owner desires to remain with company as an employee. All production, packaging and distribution is contracted to third parties with redundancies. Company primarily focuses on its domestic market and has no formal marketing or business development function. Pricing has not increased in 15 years and demand for its product is price inelastic.